GlobalData: In 2021, Lilly's weight loss drug Zepbound sold $4.1 billion in the United States
qiu539790999
发表于 2023-11-13 17:51:28
4025
0
0
According to a recent report by data analysis company GlobalData, the newly approved weight loss drug Zepbound by American pharmaceutical company Eli Lilly will have sales of $4.1 billion in the United States alone by 2031.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- GLP-1 Weight Loss Drug Production Capacity Warming Up: Lilly builds a factory in Germany for $2.5 billion and is expected to operate in 2027
- Novo Nordisk promises to invest $6 billion to expand production capacity. Prices of weight loss drugs in the United States are expected to further decrease
- American pharmaceutical company Anjin's weight loss pills have attracted attention, and Novo Nordisk's stock price has fallen by 5%
- Earning too much! US Senators indirectly pressure Novo Nordisk to lower the price of weight loss pills
- "Weight loss pills" are sold in limited quantities in China? Novo Nordisk's latest response
- Oral "weight loss medication" further advances Novo Nordisk oral semaglutide weight loss phase III research success
- Lilly weight loss pills are crazily chasing after semaglutide
- Top 20 US stock transactions: Eli Lilly rises over 4%, Biden administration plans to include weight loss drugs in healthcare and subsidy programs
- After more than two years, there is finally no shortage of Zepbound, a weight loss medication from Eli Lilly
- Lilly weight loss pills are now available for purchase on e-commerce platforms. Lilly China responds that they are self funded drugs
